ITRM20040066A1 - Metodo di identificazione di peptidi antigenici e relativo uso per la preparazione di un vaccino anti hiv-1. - Google Patents
Metodo di identificazione di peptidi antigenici e relativo uso per la preparazione di un vaccino anti hiv-1.Info
- Publication number
- ITRM20040066A1 ITRM20040066A1 ITRM20040066A ITRM20040066A1 IT RM20040066 A1 ITRM20040066 A1 IT RM20040066A1 IT RM20040066 A ITRM20040066 A IT RM20040066A IT RM20040066 A1 ITRM20040066 A1 IT RM20040066A1
- Authority
- IT
- Italy
- Prior art keywords
- vaccine
- identification
- preparation
- antigenic peptides
- related use
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
- C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16311—Human Immunodeficiency Virus, HIV concerning HIV regulatory proteins
- C12N2740/16322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITRM20040066 ITRM20040066A1 (it) | 2004-02-09 | 2004-02-09 | Metodo di identificazione di peptidi antigenici e relativo uso per la preparazione di un vaccino anti hiv-1. |
PCT/IT2005/000058 WO2005075679A2 (en) | 2004-02-09 | 2005-02-08 | Antigenic hiv-1 peptides |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITRM20040066 ITRM20040066A1 (it) | 2004-02-09 | 2004-02-09 | Metodo di identificazione di peptidi antigenici e relativo uso per la preparazione di un vaccino anti hiv-1. |
Publications (1)
Publication Number | Publication Date |
---|---|
ITRM20040066A1 true ITRM20040066A1 (it) | 2004-05-09 |
Family
ID=34835614
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ITRM20040066 ITRM20040066A1 (it) | 2004-02-09 | 2004-02-09 | Metodo di identificazione di peptidi antigenici e relativo uso per la preparazione di un vaccino anti hiv-1. |
Country Status (2)
Country | Link |
---|---|
IT (1) | ITRM20040066A1 (it) |
WO (1) | WO2005075679A2 (it) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007055260A1 (ja) * | 2005-11-11 | 2007-05-18 | Japan Health Sciences Foundation | 人免疫不全ウイルス-1遺伝子検出又は定量用材料,検出又は定量方法,治療用遺伝子断片,及び治療方法 |
JP5943433B2 (ja) | 2011-01-20 | 2016-07-05 | ワンデイ − バイオテク アンド ファーマ リミテッド | 抗酸化、抗炎症、抗放射線、金属キレート化合物およびその使用 |
CN104717970A (zh) | 2012-07-23 | 2015-06-17 | 万德-生物技术及制药有限公司 | 提高谷胱甘肽的组合物及其用途 |
EP2877194A4 (en) | 2012-07-25 | 2016-03-16 | Oneday Biotech And Pharma Ltd | Compositions and methods for increasing carnitine concentration in muscle tissue |
WO2014037712A2 (en) * | 2012-09-04 | 2014-03-13 | Genome Research Limited | Hiv-1 detection |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6623920B1 (en) * | 1999-07-09 | 2003-09-23 | Gen-Probe Incorporated | Detection of HIV-1 by nucleic acid amplification |
-
2004
- 2004-02-09 IT ITRM20040066 patent/ITRM20040066A1/it unknown
-
2005
- 2005-02-08 WO PCT/IT2005/000058 patent/WO2005075679A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2005075679A2 (en) | 2005-08-18 |
WO2005075679A3 (en) | 2005-12-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1118492T1 (el) | Φαρμακοτεχνικες μορφες εμβολιου norovirus | |
WO2006115843A3 (en) | Nipah virus vaccines | |
CY2013026I1 (el) | Πολυπεπτιδιου-εμβολια για ευρεια προστασια εναντι υπερ-λοιμογονων μηνιγγιοκοκκικων γενεαλογικων σειρων | |
CR11122A (es) | Vacuna de influenza de emulsion de aceite en agua | |
WO2004080403A3 (en) | Influenza virus vaccine | |
DE602005025342D1 (de) | Impfstoffzusammensetzungen mit virosomen und einem saponin-adjuvans | |
WO2007024947A3 (en) | Canine influenza vaccines | |
IL213189A (en) | A vaccine containing avian influenza antigen, a method for vaccinating animals with the vaccine, antigen-encoded DNA and its uses | |
WO2008124646A3 (en) | Use of amyloid proteins as vaccine scaffolds | |
CY1112786T1 (el) | Εμβολια γριπης αυθορμητως προσροφημενα σε ανοσοενισχυτικα αργιλιου | |
BRPI0921717A2 (pt) | composto, sequência de peptídeo isolada, composição farmacêutica, uso de um composto, anticorpo, e, método de tratamento | |
BRPI0815199A2 (pt) | Uso de um antígeno derivado da proteína circunsporozóite de plasmodium falciparum | |
WO2017083729A3 (en) | Fixatives and methods of use | |
ATE529123T1 (de) | Synthetische glykolipopeptide als impfstoffe | |
EA200900738A1 (ru) | Слитые белки, содержащие антигены отторжения опухоли ny-eso-1 и lage-1 | |
BRPI0516464A (pt) | formulação farmacêutica, método para a preparação de um produto farmacêutico, e, uso de uma formulação farmacêutica | |
EA200701166A1 (ru) | Альфа-тимозиновые пептиды в качестве адъювантов противораковых вакцин | |
ITRM20040066A1 (it) | Metodo di identificazione di peptidi antigenici e relativo uso per la preparazione di un vaccino anti hiv-1. | |
WO2007082105A3 (en) | Chlamydia vaccine | |
WO2007020520A3 (en) | Antigenic peptides and their use | |
DK1906921T3 (da) | Klar farmaceutisk, vandig mikroemulsion omfattende propofol og fremgangsmåde til fremstilling | |
WO2006110881A3 (en) | Yersinia polypeptide vaccines, antibodies and immunomodulatory proteins | |
DK1697405T3 (da) | LSA-5 leverstadium- og blodstadium-antigen fra Plasmodium falciparum, immunogent præparat omfattende dette antigen samt vacciner mod malaria | |
ITUA20161610A1 (it) | Composto peptidico farmacologicamente attivo, procedimento per la sua preparazione e suo uso. | |
WO2010064208A3 (en) | Msp2 antigenic peptides and their use |